Immune-related adverse events in patients treated with immunotherapy according to corticosteroid exposure

被引:0
|
作者
Meraz-Brenez, Andres
Aranda-Gutierrez, Alejandro
Jael Soliz, Dhylan
Reyes-Vanegas, Diego
Gonzalez-Sanchez, Hector Raul
Martinez-Cannon, Bertha Alejandra
Verduzco-Aguirre, Haydee Cristina
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[2] Hosp Gen Reg 1 Dr Carlos Mac Gregor Sanchez Navar, Inst Mexicano Seguro Social, Mexico City, DF, Mexico
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14709
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Circulating biomarkers of response to immunotherapy and immune-related adverse events
    Garrison, Zachary
    Hornick, Noah
    Cheng, Jeffrey
    Kulkarni, Rajan P.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2022, 22 (09) : 855 - 865
  • [22] Immune-related Adverse Events in Cancer Patients
    Pallin, Daniel J.
    Baugh, Christopher W.
    Postow, Michael A.
    Caterino, Jeffrey M.
    Erickson, Timothy B.
    Lyman, Gary H.
    ACADEMIC EMERGENCY MEDICINE, 2018, 25 (07) : 819 - 827
  • [23] Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Liang, Yao
    Maeda, Osamu
    Ando, Yuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, : 365 - 375
  • [24] Impact of immune-related adverse events (irAEs) and survival (OS) in a cohort of MPM patients (p) treated with immunotherapy (IT)
    Cedres Perez, S. M.
    Valdivia, A.
    Assaf, J. D.
    Iranzo Gomez, P.
    Callejo, A.
    Pardo Aranda, N.
    Navarro Mendivil, A. F.
    Martinez-Marti, A.
    Molina, G.
    Navarro, V.
    Gonzalo, J.
    Soleda, M.
    Frigola, J.
    Carbonell, C.
    Amat, R.
    Dienstmann, R.
    Felip, E.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1290 - S1290
  • [25] Immune-related adverse events in cancer patients being treated with immune checkpoint inhibitors
    Byrne, Margaret M.
    Lucas, Mathew
    Pai, Lori
    Breeze, Janis
    Parsons, Susan K.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (06) : 650 - 657
  • [26] Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy
    Dionese, Michele
    Bimbatti, Davide
    Pierantoni, Francesco
    Lai, Eleonora
    Erbetta, Elisa
    Cavasin, Nicolo
    Jubran, Salim
    Basso, Umberto
    Maruzzo, Marco
    ANTICANCER RESEARCH, 2024, 44 (10) : 4379 - 4386
  • [27] Immune-related adverse events and efficacy outcomes in patients treated with immunotherapy: A systematic review and meta-analysis
    Druyts, Eric
    Boye, Mark
    Agg, Himani
    Muehlenbein, Catherine
    Frederickson, Andrew
    Bayt, Theresa
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [28] Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
    Cheema, Parneet K.
    Iafolla, Marco A. J.
    Abdel-Qadir, Husam
    Bellini, Andrew B.
    Chatur, Nazira
    Chandok, Natasha
    Comondore, Vikram R.
    Cunningham, Morven
    Halperin, Ilana
    Hu, Anne B.
    Jaskolka, Diana
    Darvish-Kazem, Saeed
    Khandaker, Masud H.
    Kitchlu, Abhijat
    Sachdeva, Jasdip S.
    Shapera, Shane
    Woolnough, Nicholas R. J.
    Nematollahi, Massey
    CURRENT ONCOLOGY, 2024, 31 (10) : 6356 - 6383
  • [29] Corticosteroid-resistant immune-related adverse events: a systematic review
    Daetwyler, Eveline
    Wallrabenstein, Till
    Koenig, David
    Cappelli, Laura C.
    Naidoo, Jarushka
    Zippelius, Alfred
    Laeubli, Heinz
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [30] Immune-related adverse events and survival in elderly patients with melanoma treated with ipilimumab
    Mian, Idrees
    Yang, Ming
    Zhao, Hui
    Shah, Mohsin
    Diab, Adi
    Shannon, Vickie
    Patel, Anisha
    Amaria, Rodabe Navroze
    Giordano, Sharon Hermes
    Suarez-Almazor, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)